DOI: 10.37421/2168-9547.2023.12.396
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. The disease is characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles in the brain, which lead to the loss of neurons and cognitive decline. While the exact causes of Alzheimer's disease are not fully understood, recent research has shed light on the molecular biology and genetics underlying the disease. One of the key molecular features of Alzheimer's disease is the accumulation of plaques in the brain. Peptide that is produced through the cleavage of the Amyloid Precursor Protein (APP) by the enzymes. In healthy individuals, brain through a variety of mechanisms, including enzymatic degradation and clearance by immune cells. However, in Alzheimer's disease, accumulates in the brain, forming plaques that are toxic to neurons.
Divyalakshmi Saini and Vinay Jain
Telomeres have always been an enigmatic structure since their discovery. The unravelling of new findings and changing concept of central dogma
at telomeres have intrigued the telomere biologists further. Telomeres have been considered antennas for various environmental stress and
detectors of cellular DNA damage. The translation of mammalian telomeres has further raised many questions about its involvement in maintaining
the genomic integrity and have opened doors for new era of research in telomere biology and telomere-related diseases. Unravelling the mysteries
of telomeric organization and its regulation will have widespread impact in various fields including cancer treatment, space exploration and aging
disorders.
Molecular Biology: Open Access received 607 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 